Study outcomes | Measurement | Timepoint | |||
Baseline | Pre-discharge | 6 weeks | 12 weeks | ||
Primary outcome | |||||
Treatment beliefs | BMQ-S15 | X | X | X | X |
Secondary outcomes | |||||
Necessity beliefs | Necessity 1-item | X | X | X | X |
Concerns | Concerns 1-item | X | X | X | X |
Medicines-related self-efficacy | Self-efficacy 1-item | X | X | X | X |
Perceived illness duration | Timeline 1-item19 | X | X | X | X |
Depression | PHQ-223 | X | X | ||
Medicines-related information satisfaction | SIMS25 | X | |||
Medication adherence | MARS-521 | X | X | ||
Medicines-related self-efficacy | SEAMS27 | X | |||
Feasibility outcomes | |||||
Participant uptake | % of eligible participants that consented | X | |||
Participant retention | % of consented participants to complete study | X |
BMQ-S, Beliefs about Medicines Questionnaire-Specific; MARS-5, Medication Adherence Report Scale 5; PHQ-2, Patient Health Questionnaire-2; SEAMS, Self-Efficacy for Appropriate Medication Use Scale; SIMS, Satisfaction with Information about Medicines Scale.